Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139,065 | 122,401 | 184,186 | 173,624 | 123,436 |
| Marketable Securities | 213,996 | 292,639 | 414,227 | 540,640 | 564,833 |
| Receivables | 17,409 | 17,122 | 14,174 | 19,754 | 10,047 |
| Inventories | 19,263 | 18,231 | 18,612 | 17,422 | 14,063 |
| TOTAL | $402,748 | $467,027 | $643,729 | $764,960 | $726,914 |
| Non-Current Assets | |||||
| PPE Net | 85,262 | 87,820 | 75,235 | 56,308 | 39,692 |
| Investments And Advances | 217,145 | 217,379 | 91,131 | 30,688 | 118,525 |
| Intangibles | 127,498 | 127,927 | 128,355 | 128,778 | 129,197 |
| Other Non-Current Assets | 90,691 | 92,454 | 94,924 | 91,359 | 102,086 |
| TOTAL | $520,596 | $525,580 | $389,645 | $307,133 | $389,500 |
| Total Assets | $923,344 | $992,607 | $1,033,374 | $1,072,093 | $1,116,414 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,307 | 8,252 | 6,093 | 5,197 | 3,237 |
| Accrued Expenses | 24,985 | 29,068 | 22,169 | 18,915 | 25,112 |
| TOTAL | $113,807 | $122,382 | $116,648 | $106,768 | $105,197 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 80,460 | 79,954 | 83,553 | 78,348 | 73,319 |
| Other Non-Current Liabilities | 106,609 | 108,139 | 103,774 | 95,252 | 104,333 |
| TOTAL | $205,435 | $218,682 | $223,416 | $239,608 | $267,951 |
| Total Liabilities | $319,242 | $341,064 | $340,064 | $346,376 | $373,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141,584 | 141,132 | 140,766 | 140,311 | 139,220 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -718,891 | -657,458 | -601,555 | -552,254 | -511,612 |
| Other shareholders' equity | -1,027 | 41 | 345 | 760 | 893 |
| TOTAL | $604,102 | $651,543 | $693,310 | $725,717 | $743,266 |
| Total Liabilities And Equity | $923,344 | $992,607 | $1,033,374 | $1,072,093 | $1,116,414 |